A plant compound slowed glioma stem cells in the lab and in mice
Original title: Wogonoside Suppresses the Self-renewal Ability of Glioma Stem Cells via Down-regulating AKT/ZEB1 Signaling Pathway.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab dishes and in mice.
The short version
A compound from a plant slowed brain tumor stem cells in dishes and in mice.
What was studied. Researchers tested wogonoside, a compound from the plant Scutellaria baicalensis. They used it on two human glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary stem cell lines grown in the lab. They also tested it in mice with brain tumors.
What they found. Wogonoside made the tumor cells form fewer and smaller clusters. The cells were less able to start new tumors in the lab. Two markers that keep these cells stem like went down. In mice, the tumors grew less and the mice lived longer.
What this means, and what it doesn't
What it could mean: This points to a possible new way to target the cells that help glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary come back. It gives scientists a lead to study further.
What it doesn't mean: This does not mean wogonoside is a treatment. The work was done only in lab dishes and in mice. No person with a brain tumor was given it in this study. Many things that work in mice do not work in people. It is not a cure, and it is not something a doctor can offer now. Please do not try plant supplements on your own to copy this.
Source: PubMed, August 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.